A ground breaking drug has become available to patients with the blood cancer chronic myeloid leukaemia. Glivec has been so successful in trials that the licensing authorities have made it available for public use in almost record time.
Now more than 6,000 people suffering from Chronic Myeloid Leukaemia (CML) have a real chance of survival. Around 1,000 people a year are diagnosed with the condition and around half are dead within five years.
Read more on the Daily Mail Website by clicking HERE